Join Growin Stock Community!

Nuwellis, inc.NUWE.US Overview

US StockHealthcare
(No presentation for NUWE)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

NUWE AI Insights

NUWE Overall Performance

NUWE AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

NUWE Recent Performance

-

Nuwellis, inc.

0.05%

Avg of Sector

-0.31%

S&P500

NUWE PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

NUWE Key Information

NUWE Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

NUWE Profile

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Price of NUWE

NUWE FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

NUWE Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-18.35
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.17
PB Ratio
0.35
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
59.07%
Net Margin
-202.83%
Revenue Growth (YoY)
-8.93%
Profit Growth (YoY)
-15.48%
3-Year Revenue Growth
2.40%
3-Year Profit Growth
4.70%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-18.35
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.17
PB Ratio
0.35
Price-to-FCF
-
Gross Margin
59.07%
Net Margin
-202.83%
Revenue Growth (YoY)
-8.93%
Profit Growth (YoY)
-15.48%
3-Year Revenue Growth
2.40%
3-Year Profit Growth
4.70%

  • When is NUWE's latest earnings report released?

    The most recent financial report for Nuwellis, inc. (NUWE) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating NUWE's short-term business performance and financial health. For the latest updates on NUWE's earnings releases, visit this page regularly.

  • What is the operating profit of NUWE?

    According to the latest financial report, Nuwellis, inc. (NUWE) reported an Operating Profit of -2.7M with an Operating Margin of -121.65% this period, representing a decline of 76.04% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is NUWE's revenue growth?

    In the latest financial report, Nuwellis, inc. (NUWE) announced revenue of 2.22M, with a Year-Over-Year growth rate of -6.34%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does NUWE have?

    As of the end of the reporting period, Nuwellis, inc. (NUWE) had total debt of 383K, with a debt ratio of 0.05. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does NUWE have?

    At the end of the period, Nuwellis, inc. (NUWE) held Total Cash and Cash Equivalents of 3.09M, accounting for 0.39 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does NUWE go with three margins increasing?

    In the latest report, Nuwellis, inc. (NUWE) did not achieve the “three margins increasing” benchmark, with a gross margin of 65.2%%, operating margin of -121.65%%, and net margin of 21.2%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess NUWE's profit trajectory and future growth potential.

  • Is NUWE's EPS continuing to grow?

    According to the past four quarterly reports, Nuwellis, inc. (NUWE)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 0.56. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of NUWE?

    Nuwellis, inc. (NUWE)'s Free Cash Flow (FCF) for the period is -3.25M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 32.18% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.